Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Return on Sales (2025)

Historic Return on Sales for Coeptis Therapeutics Holdings (COEPW) over the last 1 years, with Q3 2025 value amounting to 12.21%.

  • Coeptis Therapeutics Holdings' Return on Sales changed N/A to 12.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.28%, marking a year-over-year change of. This contributed to the annual value of 179.32% for FY2021, which is N/A changed from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Return on Sales stood at 12.21%.
  • Coeptis Therapeutics Holdings' 5-year Return on Sales high stood at 12.21% for Q3 2025, and its period low was 54.41% during Q1 2025.